Floatz logo

Levoleucovorin

Squamous Cell Carcinoma of the Anus Stage Unspecified

Oncolytics BiotechPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Squamous Cell Carcinoma of the Anus Stage Unspecified cohort.

Asset / SponsorPhaseRating
Trifluridine/Tipiracil Hydrochloride Combination Agent Tas-102
Oncolytics Biotech
Phase 1/2CCC
Pelareorep
Oncolytics Biotech
Phase 1/2CCC

Same molecule, other indications

Levoleucovorin is also rated in:

gastroesophageal junction adenocarcinomaDormant
BB
Indicative ·
68 / 100
View asset →
Advanced/Metastatic Gastroesophageal AdenocarcinomaDormant
BB
Indicative ·
68 / 100
View asset →
colorectal cancerDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →